Literature DB >> 18356351

Emergency department patient knowledge concerning acetaminophen (paracetamol) in over-the-counter and prescription analgesics.

D Fosnocht1, J R Taylor, E M Caravati.   

Abstract

OBJECTIVES: This study was designed to evaluate patient knowledge of the acetaminophen (paracetamol) content of commonly used pain medications and the maximum daily recommended dose of acetaminophen.
METHODS: A prospective, convenience sample of emergency department patients were enrolled. Data were recorded using a standardised questionnaire over 4 months.
RESULTS: 1009 patients were enrolled. 492 patients (49%) did not know if Tylenol contained acetaminophen (paracetamol). The majority (66-90%) of patients did not know if Lortab, Vicodin, Percocet, non-aspirin pain reliever, ibuprofen, Motrin, or Advil contained acetaminophen. 568 patients (56%) reported not knowing the maximum daily dose of acetaminophen and only 71 patients (7%) reported the correct daily dose.
CONCLUSIONS: Patient knowledge of the acetaminophen content of commonly used analgesic medications and its maximum recommended daily dose is limited. This may contribute to unintentional repeated supratherapeutic ingestion (RSTI) of acetaminophen, or overdose.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356351     DOI: 10.1136/emj.2007.053850

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  12 in total

Review 1.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

2.  Prescription acetaminophen ingestions associated with hepatic injury and death.

Authors:  Richard M Martinez; Sean Patrick Nordt; F Lee Cantrell
Journal:  J Community Health       Date:  2012-12

3.  Risk of unintentional overdose with non-prescription acetaminophen products.

Authors:  Michael S Wolf; Jennifer King; Kara Jacobson; Lorenzo Di Francesco; Stacy Cooper Bailey; Rebecca Mullen; Danielle McCarthy; Marina Serper; Terry C Davis; Ruth M Parker
Journal:  J Gen Intern Med       Date:  2012-05-26       Impact factor: 5.128

4.  Variability in Acetaminophen Labeling Practices: a Missed Opportunity to Enhance Patient Safety.

Authors:  Jennifer P King; Danielle M McCarthy; Marina Serper; Kara L Jacobson; Rebecca J Mullen; Ruth M Parker; Michael S Wolf
Journal:  J Med Toxicol       Date:  2015-12

5.  Risk Factors, Clinical Presentation, and Outcomes in Overdose With Acetaminophen Alone or With Combination Products: Results From the Acute Liver Failure Study Group.

Authors:  Marina Serper; Michael S Wolf; Nikhil A Parikh; Holly Tillman; William M Lee; Daniel R Ganger
Journal:  J Clin Gastroenterol       Date:  2016-01       Impact factor: 3.062

6.  [Paracetamol for perioperative analgesia. Old substance - new insights].

Authors:  P K Zahn; R Sabatowski; S A Schug; U M Stamer; E M Pogatzki-Zahn
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

7.  Paracetamol overdose secondary to dental pain: a case series.

Authors:  I Siddique; H Mahmood; R Mohammed-Ali
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

8.  Limited Knowledge of Acetaminophen in Patients with Liver Disease.

Authors:  Sammy Saab; Peter G Konyn; Matthew R Viramontes; Melissa A Jimenez; Jonathan F Grotts; Wally Hamidzadah; Veronica P Dang; Negin L Esmailzadeh; Gina Choi; Francisco A Durazo; Mohamed M El-Kabany; Steven-Huy B Han; Myron J Tong
Journal:  J Clin Transl Hepatol       Date:  2016-12-27

Review 9.  Predicting drug side-effects by chemical systems biology.

Authors:  Nicholas P Tatonetti; Tianyun Liu; Russ B Altman
Journal:  Genome Biol       Date:  2009-09-02       Impact factor: 13.583

10.  Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System.

Authors:  Carrie Lorenz; Wendolyn Sandoval; Mark Mortellaro
Journal:  Diabetes Technol Ther       Date:  2018-03-30       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.